risks of glp 1 Overdose increase as demand for injectable weight-loss drugs on the rise, research finds Unlocking the broad health benefits

Primary outcomes included serious adverse events and retained gastric products based on patient records, procedure reports, and procedural videos

Semaglutide, the active ingredient in GLP-1 drugs, was associated with a lower risk of worsening mental health, a study published in Lancet Psychiatry found.

Unlike diabetic ketoacidosis, the diagnosis of euglycemic diabetic ketoacidosisis often overlooked because of the absence of hyperglycemia.

Overview on biological glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) effects at the organ/tissue level.

Struggling with GLP-1 therapy side effects